Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Am Surg ; 78(11): 1228-31, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23089440

ABSTRACT

Cystic duct leakage with metal clips persists after laparoscopic cholecystectomy (LC). The aim of the study is to evaluate the preventive effect of locking clips on leaks from the cystic duct stump after LC as an alternative to metal clips. Locking clips were routinely used to close the cystic duct in LC. A total of 1101 patients who underwent LC were retrospectively assessed from a database of the surgical department at our university hospital. A main outcome measurement is bile leakage after LC. From January 2006 to April 2011, 1053 LCs were performed. Of these, the cystic duct was closed with locking clips in 1017 cases, and no bile leaks from the cystic duct were observed in any of these 1017 cases. Locking clips should be routinely used to close the cystic duct in preference to metallic clips to reduce postoperative bile leaks after LC.


Subject(s)
Cholecystectomy, Laparoscopic/instrumentation , Cystic Duct/surgery , Aged , Cholecystectomy, Laparoscopic/adverse effects , Equipment Design , Female , Humans , Male , Middle Aged , Postoperative Complications/prevention & control , Retrospective Studies , Surgical Instruments
2.
Surg Endosc ; 23(10): 2307-13, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19184202

ABSTRACT

BACKGROUND: A better method for detecting early peritoneal progression is needed. This study evaluated the feasibility and accuracy of second-look laparoscopy for patients with gastric cancer treated using systemic chemotherapy after gastrectomy. METHODS: Second-look laparoscopy was conducted for patients who had no clinical evidence of distant metastases but had peritoneal metastases or positive peritoneal cytology results without visible metastatic disease at initial surgery, patients who underwent systemic chemotherapy over a 6-month period after surgery, and patients who had no clinical evidence of disease based on imaging study after completion of primary chemotherapy. RESULTS: Between November 2004 and April 2008, 21 patients underwent second-look laparoscopy. At the initial surgery, 13 of these patients underwent total gastrectomy and 8 patients underwent distal gastrectomy. One or two sheets of adhesion barrier were received by 18 patients. The median interval between initial surgery and second-look laparoscopy was 9.8 months (range, 6.6-17.5 months). All second-look procedures were completed laparoscopically, and no patients required conversion to laparotomy. None of the 21 patients experienced postlaparoscopy complications. Whereas 12 patients showed no pathologic evidence of disease, 9 patients showed disease at second-look laparoscopy. There was a significant difference in median survival between the groups with negative and positive results (p = 0.017). The median survival for the negative group has not been determined. All the patients in the positive group received further chemotherapy while showing a good performance status (PS). Six patients were PS 0, and 3 patients were PS 1. The median survival time for this group was 10.1 months. CONCLUSIONS: Second-look laparoscopy was a safe and promising approach to reassessment of peritoneal disease for patients with gastric cancer. The incidence of complications was low, particularly in this group of patients, all of whom had undergone prior gastrectomy.


Subject(s)
Gastrectomy/methods , Laparoscopy , Peritoneal Neoplasms/surgery , Stomach Neoplasms/surgery , Adult , Aged , Disease Progression , Feasibility Studies , Female , Humans , Male , Middle Aged , Peritoneal Neoplasms/diagnosis , Peritoneal Neoplasms/secondary , Second-Look Surgery , Stomach Neoplasms/drug therapy , Stomach Neoplasms/pathology , Survival Rate
3.
Gan To Kagaku Ryoho ; 35(5): 821-3, 2008 May.
Article in Japanese | MEDLINE | ID: mdl-18487921

ABSTRACT

The patient was a 54-year-old female with gastric cancer. As laparotomy showed diffuse peritoneal dissemination, only laparotomy was performed and chemotherapy was conducted with a combination of S-1 80 mg/m(2) (2 weeks administration and 1 week rest) and paclitaxel (PTX) 50 mg/m(2) (day 1, 8). After 5 courses of this regimen, endoscopy showed the tumor was reduced in size and PET-CT revealed no evidence of metastasis. She underwent total gastrectomy with D2 lymph node dissection and Roux-en Y reconstruction. Peritoneal metastasis histologically disappeared, and the final findings were T1, N0, H0, P0, CY0, M0, Stage I A, Cur A. The only adverse effect was grade 1 stomatitis during this chemotherapy. CT showed no findings of recurrence 11 months after the operation. The S-1/PTX combination chemotherapy was thought to be effective for gastric cancer with peritoneal dissemination and made curative operation possible in this case.


Subject(s)
Adenocarcinoma/therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Gastrectomy , Peritoneal Neoplasms/pathology , Stomach Neoplasms/therapy , Antimetabolites, Antineoplastic/administration & dosage , Antineoplastic Agents, Phytogenic/administration & dosage , Combined Modality Therapy , Drug Combinations , Female , Humans , Middle Aged , Oxonic Acid/administration & dosage , Paclitaxel/administration & dosage , Peritoneal Neoplasms/therapy , Tegafur/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...